Imunon annual operating margin
2017
2018
2019
2020
2021
2022
Imunon Operating Margin Growth & History (IMNN)
Imunon's operating margin was −4,984.31% for fiscal 2022.
View full Imunon company overviewImunon annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-12-31 | −4,984.31% | −782.88 pp |
| 2021 | 2021-12-31 | −4,201.44% | −504.16 pp |
| 2020 | 2020-12-31 | −3,697.28% | +415.81 pp |
| 2019 | 2019-12-31 | −4,113.09% | +99.91 pp |
| 2018 | 2018-12-31 | −4,213.01% | −519.32 pp |
| 2017 | 2017-12-31 | −3,693.69% | — |
Imunon quarterly operating margin
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q3.15
Q4.15
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2022 | 2022-12-31 | −5,541.40% | −1148.71 pp |
| Q3 2022 | 2022-09-30 | −4,939.65% | −890.39 pp |
| Q2 2022 | 2022-06-30 | −4,782.62% | −725.50 pp |
| Q1 2022 | 2022-03-31 | −4,673.58% | −366.91 pp |
| Q4 2021 | 2021-12-31 | −4,392.69% | −557.61 pp |
| Q3 2021 | 2021-09-30 | −4,049.26% | −721.58 pp |
| Q2 2021 | 2021-06-30 | −4,057.12% | −243.52 pp |
| Q1 2021 | 2021-03-31 | −4,306.68% | −493.91 pp |
| Q4 2020 | 2020-12-31 | −3,835.09% | −36.96 pp |
| Q3 2020 | 2020-09-30 | −3,327.68% | +982.34 pp |
| Q2 2020 | 2020-06-30 | −3,813.60% | +642.21 pp |
| Q1 2020 | 2020-03-31 | −3,812.76% | +75.65 pp |
| Q4 2019 | 2019-12-31 | −3,798.13% | +2.16 pp |
| Q3 2019 | 2019-09-30 | −4,310.02% | −1092.24 pp |
| Q2 2019 | 2019-06-30 | −4,455.81% | +1953.28 pp |
| Q1 2019 | 2019-03-31 | −3,888.42% | −463.54 pp |
| Q4 2018 | 2018-12-31 | −3,800.29% | +82.78 pp |
| Q3 2018 | 2018-09-30 | −3,217.78% | +300.70 pp |
| Q2 2018 | 2018-06-30 | −6,409.08% | −2890.60 pp |
| Q1 2018 | 2018-03-31 | −3,424.88% | +429.84 pp |
| Q4 2017 | 2017-12-31 | −3,883.07% | — |
| Q3 2017 | 2017-09-30 | −3,518.48% | — |
| Q2 2017 | 2017-06-30 | −3,518.48% | — |
| Q1 2017 | 2017-03-31 | −3,854.72% | — |
| Q4 2015 | 2015-12-31 | −3,957.51% | +1187.64 pp |
| Q3 2015 | 2015-09-30 | −3,393.69% | +1941.34 pp |
| Q1 2015 | 2015-03-31 | −5,130.60% | −968.98 pp |
| Q4 2014 | 2014-12-31 | −5,145.15% | — |
| Q3 2014 | 2014-09-30 | −5,335.03% | — |
| Q2 2014 | 2014-06-30 | −5,130.36% | — |
| Q1 2014 | 2014-03-31 | −4,161.62% | — |
Imunon operating margin trends
Over the last five fiscal years, Imunon's operating margin decreased from −3,693.69% to −4,984.31%, a change of −1290.63 percentage points. The latest reported quarter, Q4 2022, shows −5,541.40%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Imunon source filings ↗Community posts
IMUNON signs an NCI agreement to expand development of IMNN-001
IMUNON ($IMNN) entered a Cooperative Research and Development Agreement with the US National Cancer Institute for IMNN-001, its DNA-based IL-12 immunotherapy. NCI’s Cancer Therapy Evaluation Program will assume regulatory sponsorship and su ...
